| 2.3 |
9.1 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 2.0 |
5.9 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 1.4 |
4.2 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 1.4 |
4.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 1.3 |
5.0 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.1 |
3.3 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 1.1 |
4.4 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 1.0 |
3.0 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 1.0 |
2.9 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 1.0 |
6.8 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.9 |
4.7 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.9 |
2.8 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.9 |
2.8 |
GO:0070671 |
activation of meiosis involved in egg activation(GO:0060466) response to interleukin-12(GO:0070671) positive regulation of acrosome reaction(GO:2000344) |
| 0.9 |
2.7 |
GO:0010751 |
regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.9 |
2.7 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.9 |
4.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.8 |
4.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.8 |
2.5 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.8 |
2.5 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.8 |
2.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.8 |
4.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.8 |
1.6 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.8 |
2.4 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.8 |
4.6 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.8 |
3.0 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.8 |
2.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.7 |
2.2 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.7 |
3.0 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.7 |
7.3 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.7 |
6.5 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.7 |
2.8 |
GO:0061428 |
embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.7 |
2.0 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.7 |
3.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.7 |
3.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.6 |
2.6 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.6 |
1.9 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.6 |
1.3 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.6 |
2.5 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.6 |
1.9 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.6 |
2.4 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.6 |
1.7 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.6 |
6.4 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.6 |
5.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.6 |
1.7 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.6 |
1.7 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.6 |
1.7 |
GO:0046881 |
sperm ejaculation(GO:0042713) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.5 |
1.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 |
1.6 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.5 |
3.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.5 |
1.0 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.5 |
1.5 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.5 |
0.5 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.5 |
3.0 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.5 |
2.4 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.5 |
0.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.5 |
1.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.5 |
2.8 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.5 |
0.9 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.5 |
1.9 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.5 |
2.3 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.5 |
1.8 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.4 |
11.2 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.4 |
5.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.4 |
1.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.4 |
0.8 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.4 |
0.8 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.4 |
2.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.4 |
0.8 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.4 |
1.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.4 |
1.2 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.4 |
1.6 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.4 |
2.4 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 |
2.0 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.4 |
2.0 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.4 |
6.7 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.4 |
1.6 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.4 |
1.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.4 |
1.1 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.4 |
4.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.4 |
4.9 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.4 |
1.9 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.4 |
0.4 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.4 |
0.7 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.4 |
2.6 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.4 |
4.8 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.4 |
1.1 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.4 |
1.1 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.4 |
1.4 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.4 |
1.4 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.4 |
2.5 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.4 |
1.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.3 |
2.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 |
1.7 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.3 |
0.7 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
7.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.3 |
1.0 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.3 |
2.3 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.3 |
1.0 |
GO:2000834 |
luteinizing hormone secretion(GO:0032275) androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 |
1.3 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.3 |
0.6 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 |
3.8 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 |
0.9 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.3 |
0.9 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.3 |
1.9 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.3 |
1.3 |
GO:0071105 |
response to interleukin-11(GO:0071105) osteoclast fusion(GO:0072675) |
| 0.3 |
3.1 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.3 |
0.3 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.3 |
2.2 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.3 |
1.5 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.3 |
1.8 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.3 |
1.2 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.3 |
1.8 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.3 |
5.4 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 |
1.2 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.3 |
1.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
1.2 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.3 |
0.6 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.3 |
1.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
14.8 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.3 |
9.5 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.3 |
3.4 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.3 |
1.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 |
6.4 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.3 |
2.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.3 |
0.8 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.3 |
1.4 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.3 |
1.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
2.2 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 |
1.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 |
0.5 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.3 |
2.9 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.3 |
0.3 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.3 |
1.8 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.3 |
1.0 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.3 |
0.3 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.3 |
0.8 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 |
2.5 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.5 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.2 |
0.7 |
GO:1903722 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) late endosomal microautophagy(GO:0061738) regulation of centriole elongation(GO:1903722) |
| 0.2 |
3.8 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.2 |
3.3 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 |
5.3 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 |
0.7 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
1.4 |
GO:0032308 |
positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 |
1.6 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.2 |
0.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
0.9 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
5.6 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.2 |
1.8 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.2 |
0.4 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 |
1.3 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
1.3 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.2 |
0.8 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.2 |
0.6 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
1.2 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 |
1.6 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 |
1.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
0.8 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
1.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 |
0.4 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) negative regulation of interleukin-18 production(GO:0032701) |
| 0.2 |
1.9 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
1.5 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
1.1 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 |
0.9 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
1.2 |
GO:0051461 |
protein import into peroxisome matrix, docking(GO:0016560) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
2.7 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.2 |
0.4 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.2 |
2.8 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.2 |
2.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
2.8 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.2 |
0.2 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
2.3 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.2 |
0.8 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.2 |
0.3 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.2 |
1.0 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.2 |
4.4 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 |
1.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 |
0.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
3.2 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
0.3 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.2 |
0.6 |
GO:0060315 |
L-ascorbic acid metabolic process(GO:0019852) water-soluble vitamin biosynthetic process(GO:0042364) negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 |
3.8 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
0.9 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
1.7 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 |
1.1 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.2 |
1.9 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 |
1.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
0.9 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 |
0.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.9 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
1.4 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
1.0 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.1 |
1.1 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.7 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
1.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.7 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
1.1 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.6 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
3.5 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.7 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.1 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.1 |
1.8 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.4 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
2.8 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.5 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.9 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.1 |
0.5 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
2.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
2.4 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.1 |
0.9 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
1.6 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.6 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.5 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.6 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
0.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.8 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
1.6 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
0.4 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
0.5 |
GO:2000427 |
eosinophil chemotaxis(GO:0048245) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
2.8 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
2.7 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
| 0.1 |
5.7 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.1 |
3.1 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
2.5 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
3.9 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
0.9 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
1.4 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
0.3 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
2.0 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
1.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
1.2 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
1.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.9 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.5 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
1.7 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
1.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
2.2 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.1 |
0.9 |
GO:0071353 |
response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.1 |
3.4 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
0.4 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.8 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
3.2 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.1 |
0.7 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.5 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.3 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
0.9 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
1.4 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.5 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.1 |
0.2 |
GO:0050999 |
regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.1 |
1.0 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 |
5.8 |
GO:0003281 |
ventricular septum development(GO:0003281) |
| 0.1 |
0.6 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.3 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
0.8 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
0.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.4 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
1.4 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.8 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
1.0 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.8 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.3 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.8 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
1.9 |
GO:0060384 |
innervation(GO:0060384) |
| 0.1 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 |
0.7 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
1.0 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
1.3 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.1 |
3.4 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.6 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.1 |
0.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
2.2 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.1 |
0.8 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.4 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
1.7 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.6 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.1 |
0.4 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
0.3 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
0.6 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.5 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.4 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.9 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.3 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
1.0 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
1.1 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
1.3 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
1.9 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.1 |
1.2 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 |
0.1 |
GO:0070230 |
positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
0.5 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.6 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.1 |
0.4 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
1.6 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 |
0.4 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
1.9 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
1.1 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.4 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.4 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.9 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
2.0 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.4 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
1.7 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 |
1.7 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.4 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
0.1 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
0.4 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.9 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.1 |
0.8 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.4 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.3 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 |
0.2 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
1.2 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.1 |
1.4 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
1.1 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.9 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.0 |
1.5 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.2 |
GO:0015692 |
nickel cation transport(GO:0015675) vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.0 |
0.9 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.0 |
0.6 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
0.6 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.8 |
GO:0006744 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
1.0 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.4 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.4 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
1.9 |
GO:0035725 |
sodium ion transmembrane transport(GO:0035725) |
| 0.0 |
0.3 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 |
1.0 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.7 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.6 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.2 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.2 |
GO:0008306 |
associative learning(GO:0008306) |
| 0.0 |
0.5 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
2.1 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.5 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.9 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.3 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.0 |
0.3 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
1.3 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 |
0.5 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.6 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.0 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
1.0 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.4 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.0 |
0.6 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.2 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.3 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.0 |
0.9 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 |
0.3 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.6 |
GO:0018107 |
peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 |
0.6 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.0 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.0 |
0.2 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.4 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
1.2 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.1 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.0 |
0.2 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.9 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.6 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.4 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 |
0.5 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.7 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.2 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.7 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.6 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.8 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.3 |
GO:1903393 |
positive regulation of adherens junction organization(GO:1903393) |
| 0.0 |
0.2 |
GO:0021702 |
cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 |
0.2 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.6 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.0 |
1.2 |
GO:0030534 |
adult behavior(GO:0030534) |
| 0.0 |
0.2 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
1.8 |
GO:0050890 |
cognition(GO:0050890) |
| 0.0 |
0.4 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.5 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.8 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 |
0.1 |
GO:0042053 |
regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
| 0.0 |
0.1 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
